29.01
1.21 (4.35%)
1.21 (4.35%)
Upgrade to Real-Time
Regular Market
| Volume | 185,709 |
|
|||||
| News | - | ||||||
| Day High | 29.45 | Low High |
|||||
| Day Low | 27.11 | ||||||
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Reata Pharmaceuticals Inc | RETA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| 1.21 | 4.35% | 29.01 | 11:25:56 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 28.38 | 27.11 | 29.45 | 27.80 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,998 | 185,709 | $ 28.27 | $ 5,249,148 | - | 20.235 - 153.41 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 11:25:55 | 5 | $ 29.04 | USD |
Period:
Draw Mode:
Reata Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 1.06B | 36.46M | 20.30M | $ 11.49M | $ - | -8.18 | -3.20 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 519.53k | 1.10% |
Reata Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RETA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 28.01 | 29.45 | 25.84 | 27.73 | 559,809 | 1.00 | 3.57% |
| 1 Month | 26.58 | 29.45 | 20.235 | 25.56 | 508,006 | 2.43 | 9.14% |
| 3 Months | 30.90 | 40.64 | 20.235 | 30.68 | 629,328 | -1.89 | -6.12% |
| 6 Months | 82.00 | 95.3447 | 20.235 | 32.60 | 820,558 | -52.99 | -64.62% |
| 1 Year | 126.85 | 153.41 | 20.235 | 56.26 | 557,679 | -97.84 | -77.13% |
| 3 Years | 87.26 | 257.965 | 20.235 | 104.83 | 429,256 | -58.25 | -66.75% |
| 5 Years | 26.79 | 257.965 | 19.31 | 91.28 | 353,509 | 2.22 | 8.29% |
Reata Pharmaceuticals Description
| Reata Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing therapeutics to address serious and life-threatening diseases by targeting molecular pathways. The company's product in the pipeline include bardoxolone methyl; Omaveloxolone and others. |